Work

Impact of infusing the cholesterol precursor mevalonate on the hypocholesterolemia of sepsis and its potential consequences: a paradoxical response

Year: 2026

Type: article

Abstract: Prolonged infusion with the cholesterol precursor, mevalonate, worsened hypocholesterolemia in a mouse model of sepsis-induced critical illness, likely due to increased feedback on hepatic cholesterol synthesis. Loss of muscle force and mass was not further affected, nor did mevalonate affect adrenal gland steroidogenic markers and the loss of adrenocortical lipids. In prolonged sepsis patients, sustained HDL and LDL hypocholesterolemia was observed in the face of high plasma mevalonate concentrations, but did not correlate with plasma cortisol.

Source: American Journal of Physiology-Endocrinology and Metabolism

DOI: 10.1152/ajpendo.00514.2025